CSL insider plans Rule 144 sale of 19,318 shares
CSL filed a Rule 144 notice for the proposed sale of 19,318 shares of common stock through UBS Financial Services on NASDAQ.
Rhea-AI Filing Summary
CSL filed a Rule 144 notice for the proposed sale of 19,318 shares of common stock through UBS Financial Services on NASDAQ.
The filing lists an aggregate market value of 7,727,200 for these shares and notes 41,700,000 shares of common stock outstanding. The shares to be sold come from option exercises, restricted stock awards, and performance stock units acquired between 02/02/2024 and 02/10/2026.
Positive
- None.
Negative
- None.
Insights
CSL insider files to sell 19,318 shares under Rule 144, a routine planned sale disclosure.
The notice covers 19,318 CSL common shares with an aggregate market value of 7,727,200, to be sold on NASDAQ through UBS Financial Services Inc. Total common shares outstanding are stated as 41,700,000, providing context for the scale of the planned sale.
The securities were acquired via option exercises, restricted stock award vesting, and performance stock unit vesting between 02/02/2024 and 02/10/2026, with at least one transaction paid in cash. The seller represents they are not aware of undisclosed material adverse information, which aligns with Rule 144 and insider trading safeguards.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the role of UBS Financial Services in the CSL Form 144 filing?
What assurances does the seller provide in the CSL Rule 144 notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.